A Vaccine against Cancer: Can There Be a Possible Strategy to Face the Challenge? Possible Targets and Paradoxical

Roberto Zefferino1, Massimo Conese2

  • 1Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.

Vaccines
|November 25, 2023
PubMed

Insights

Developing a cancer vaccine to prevent metastasis could transform cancer into a manageable chronic disease. This approach targets the spread of cancer, offering new hope for eradication.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Traditional cancer vaccines face challenges due to cancer's diversity and unknown causes.
  • Current research focuses on immune system stimulation and enhancing chemotherapy, but metastasis remains a critical issue.
  • Metastasis is the primary cause of cancer-related death, highlighting the need for targeted prevention strategies.

Purpose of the Study:

  • To propose a novel vaccine strategy focused on preventing cancer metastasis.
  • To explore the potential of transforming cancer into a chronic, manageable disease by inhibiting metastasis.
  • To identify viable targets for a metastasis-targeting cancer vaccine.

Main Methods:

  • Reviewing the current state of cancer vaccine research and its limitations.
  • Analyzing the complex mechanisms, pathways, and cellular components of the tumor microenvironment and pre-metastatic niche.
  • Evaluating paradoxical actions of various factors within the tumor microenvironment to identify suitable vaccine targets.

Main Results:

  • The complexity of metastatic processes and the tumor microenvironment presents significant challenges.
  • Paradoxical actions of key molecules and cells within the tumor microenvironment require careful consideration for vaccine development.
  • Specific targets for a metastasis-targeting vaccine have been identified through meticulous evaluation.

Conclusions:

  • A paradigm shift in cancer vaccine development is necessary, moving beyond traditional approaches.
  • Focusing on metastasis prevention offers a more promising strategy for improving patient outcomes and potentially eradicating cancer.
  • Redirecting scientific efforts toward metastasis-targeting vaccines could significantly increase hope for cancer eradication.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K